Textronics gets FDA-approval for textile-based electrode

Textronics, a company that manufactures wearable sensors, has received FDA clearance to market its textile-based ECG Electrode for use in general electrocardiograph monitoring and recording procedures.

The company said its heart-sensing fabric offers an alternative to adhesive electrodes and metal wristbands that are commonly used with most ECG instruments on the market.

"We're offering the medical community a more comfortable and less cumbersome solution that can improve patient compliance by eliminating skin irritation and other discomforts that are commonly experienced during ECG monitoring, especially in extended wear applications," said Textronics CEO Stacey Burr.

Textronics said its patented technology knits conductive sensing fibers directly into machine-washable stretchy fabrics that can monitor physiological conditions comfortably and accurately.

The sensors can be used for a range of ECG monitoring and recording applications, including cardiac event recorders, stress testing, Holter monitoring, trans-telephonic pacemaker monitors, and respiration sensing devices, the Wilmington-Del.-based company said.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.